Abstract
The field of oral and maxillofacial surgery has made a concerted effort to promote responsible opioid prescribing for postoperative pain control. A 2020 white paper from the American Association of Oral and Maxillofacial Surgeons (AAOMS) highlights some of these efforts, which includes supporting the mandatory usage of prescription drug monitoring programs, promoting continuing education courses, and developing evidence-based prescription guidelines.1 However, the job is not finished, as the opioid epidemic remains a public health challenge in the United States.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
